| scholarly article | Q13442814 |
| P2093 | author name string | S R Sheela | |
| Dayanand Cd | |||
| Ranjeeta Gadde | |||
| P2860 | cites work | ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis | Q81920506 |
| A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound | Q82068160 | ||
| Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study | Q82737458 | ||
| Cytokine profile in the endometrium of normal fertile and women with repeated implantation failure | Q83142577 | ||
| PP13 mRNA expression in the cellular component of maternal blood as a marker for preeclampsia | Q84669835 | ||
| A novel exonic variant (221delT) in the LGALS13 gene encoding placental protein 13 (PP13) is associated with preterm labour in a low risk population | Q84692959 | ||
| First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia | Q85029222 | ||
| Plasma PP13 and urinary GAGs/PGs as early markers of pre-eclampsia | Q89400624 | ||
| Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age. | Q50879778 | ||
| First trimester maternal serum placental protein 13 levels in singleton vs. twin pregnancies with and without severe pre-eclampsia. | Q50943224 | ||
| Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways. | Q50992588 | ||
| Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 Weeks | Q51636982 | ||
| Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies. | Q51711581 | ||
| A fast flexible docking method using an incremental construction algorithm. | Q52298930 | ||
| Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. | Q54644655 | ||
| Letter: Maternal blood group A and pre-eclampsia. | Q55352407 | ||
| Placental Protein 13 and Decidual Zones of Necrosis: An Immunologic Diversion That May be Linked to Preeclampsia | Q56794716 | ||
| First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia | Q57076624 | ||
| Maternal serum placental protein 13 at 11â 13 weeks of gestation in preeclampsia | Q61847857 | ||
| Placenta-bound and Body Fluid PP13 and its mRNA in Normal Pregnancy Compared to Preeclampsia, HELLP and Preterm Delivery | Q61865433 | ||
| Longitudinal Determination of Serum Placental Protein 13 during Development of Preeclampsia | Q61865449 | ||
| Binding studies of adhesion/growth-regulatory galectins with glycoconjugates monitored by surface plasmon resonance and NMR spectroscopy | Q62620988 | ||
| Case-control study of maternal blood group and severe pre-eclampsia | Q70791791 | ||
| The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands | Q72289424 | ||
| Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent | Q72891652 | ||
| Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia | Q79719767 | ||
| First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes | Q80473260 | ||
| Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation | Q81446879 | ||
| Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein | Q22010697 | ||
| Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion | Q24292272 | ||
| A cytoplasmic protein, bystin, interacts with trophinin, tastin, and cytokeratin and may be involved in trophinin-mediated cell adhesion between trophoblast and endometrial epithelial cells | Q24310074 | ||
| A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death | Q24317162 | ||
| Potential role of macrophages as immunoregulators of pregnancy | Q24801262 | ||
| Pre-eclampsia: its pathogenesis and pathophysiolgy | Q26746841 | ||
| Specificity of human galectins on cell surfaces | Q26779024 | ||
| Regional changes of placental vascularization in preeclampsia: a review | Q26798340 | ||
| Galectins: guardians of eutherian pregnancy at the maternal-fetal interface | Q26823092 | ||
| Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy | Q26861380 | ||
| The complement system and adverse pregnancy outcomes | Q26863600 | ||
| Structural basis of multivalent galactose-based dendrimer recognition by human galectin-7 | Q27696127 | ||
| Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins | Q27733275 | ||
| X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution | Q27757331 | ||
| The Lectin Frontier Database (LfDB), and data generation based on frontal affinity chromatography | Q28086877 | ||
| The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes | Q28204640 | ||
| Galectins. Structure and function of a large family of animal lectins | Q28246794 | ||
| Functional analyses of placental protein 13/galectin-13 | Q28249207 | ||
| Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17) | Q28275001 | ||
| PP13, maternal ABO blood groups and the risk assessment of pregnancy complications | Q28742192 | ||
| Syncytiotrophoblast extracellular vesicles - Circulating biopsies reflecting placental health. | Q30356149 | ||
| PP13 mRNA expression in trophoblasts from preeclamptic placentas | Q33393566 | ||
| Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran | Q33646081 | ||
| God must love galectins; he made so many of them | Q33751857 | ||
| Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array | Q33761815 | ||
| Relationship between maternal immunological response during pregnancy and onset of preeclampsia | Q33765975 | ||
| HLA-G as a tolerogenic molecule in transplantation and pregnancy | Q34038019 | ||
| Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). | Q34104978 | ||
| An immunological insight into the origins of pre-eclampsia | Q34109946 | ||
| Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system | Q34223964 | ||
| The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure | Q34326042 | ||
| Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. | Q34326623 | ||
| Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia | Q34328411 | ||
| Liaison between natural killer cells and dendritic cells in human gestation | Q34339782 | ||
| Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy | Q34379583 | ||
| Trophinin-mediated cell adhesion induces apoptosis of human endometrial epithelial cells through PKC-δ | Q34621052 | ||
| First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction | Q34647428 | ||
| The role of the maternal immune system in the regulation of human birthweight | Q35008470 | ||
| First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia | Q35124240 | ||
| Pre-eclampsia: pathophysiology, diagnosis, and management | Q35141777 | ||
| Subclassification of preeclampsia | Q35196220 | ||
| The immunology of successful pregnancy | Q35202645 | ||
| Annexin-A5 promotes membrane resealing in human trophoblasts. | Q35543998 | ||
| Introduction to galectins | Q35646606 | ||
| First-trimester prediction of preeclampsia in nulliparous women at low risk | Q35988764 | ||
| The Th1:th2 dichotomy of pregnancy and preterm labour. | Q36037674 | ||
| PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia? | Q36065327 | ||
| Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. | Q36093631 | ||
| Why is placentation abnormal in preeclampsia? | Q36119044 | ||
| Toll-like receptors and their role in the trophoblast | Q36182212 | ||
| B7 family molecules as regulators of the maternal immune system in pregnancy | Q36185034 | ||
| Placental protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome. | Q36480074 | ||
| Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls | Q36672096 | ||
| Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum? | Q36833655 | ||
| Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR). | Q36847097 | ||
| Actin in membrane trafficking | Q36872597 | ||
| T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. | Q36985070 | ||
| Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta | Q37433278 | ||
| First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 | ||
| The global impact of pre-eclampsia and eclampsia | Q37493240 | ||
| O Blood Group as Risk Factor for Preeclampsia among Sudanese Women | Q37523564 | ||
| Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders | Q37788456 | ||
| Bridging membrane and cytoskeleton dynamics in the secretory and endocytic pathways | Q37970880 | ||
| Review: Biochemical markers to predict preeclampsia | Q37971237 | ||
| First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review | Q38022895 | ||
| New developments in the area of factor XIII. | Q38070913 | ||
| 'Sweetening' pregnancy: galectins at the fetomaternal interface | Q38081185 | ||
| Redefining preeclampsia using placenta-derived biomarkers. | Q38086495 | ||
| Expression and function of galectins in the endometrium and at the human feto-maternal interface | Q38126229 | ||
| The up side of decidual natural killer cells: new developments in immunology of pregnancy | Q38164418 | ||
| The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus | Q38226372 | ||
| Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting | Q38293785 | ||
| The galectin lattice at a glance | Q38532853 | ||
| Placental Protein 13 Administration to Pregnant Rats Lowers Blood Pressure and Augments Fetal Growth and Venous Remodeling | Q38969936 | ||
| Placental protein 13 as an early predictor in Egyptian patients with preeclampsia, correlation to risk, and association with outcome | Q38985808 | ||
| The choriocarcinoma cell line BeWo: syncytial fusion and expression of syncytium-specific proteins | Q39669334 | ||
| Biological and clinical aspects of plasminogen activator inhibitor type 2. | Q40378014 | ||
| Is there any relationship between ABO/Rh blood group and patients with pre-eclampsia? | Q40806230 | ||
| Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors | Q40962908 | ||
| Immunologic aspects of pre-eclampsia | Q41078255 | ||
| Galectins, a class of unconventional lectins | Q41172644 | ||
| Galectins: a family of animal lectins that decipher glycocodes | Q41201922 | ||
| Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function | Q42373442 | ||
| Thermodynamic analysis of the binding of galactose and poly-N-acetyllactosamine derivatives to human galectin-3. | Q43660024 | ||
| Effects of calcium, magnesium, low-dose aspirin and low-molecular-weight heparin on the release of PP13 from placental explants | Q43952086 | ||
| ABO and RhD blood groups and gestational hypertensive disorders: a population-based cohort study | Q43976016 | ||
| Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides | Q44630393 | ||
| Placental protein 13 as a first trimester screening marker for aneuploidy | Q44807292 | ||
| Placenta-derived exosomes: potential biomarkers of preeclampsia | Q45035228 | ||
| Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. | Q45158458 | ||
| Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation | Q45244862 | ||
| Maternal ABO blood group and adverse pregnancy outcomes | Q45749131 | ||
| Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents | Q45783688 | ||
| Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks | Q46321423 | ||
| Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study | Q46334817 | ||
| The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. | Q47348629 | ||
| First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk | Q47872838 | ||
| Elevated maternal placental protein 13 serum levels at term of pregnancy in postpartum major hemorrhage (>1000 mLs). A prospective cohort study | Q48140008 | ||
| Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. | Q50515728 | ||
| P921 | main subject | pre-eclampsia | Q61335 |
| P304 | page(s) | 1849454418786159 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Journal of Circulating Biomarkers | Q50814778 |
| P1476 | title | Placental protein 13: An important biological protein in preeclampsia | |
| P478 | volume | 7 |
Search more.